scholarly journals Hematopoietic stem cell transplantation in children with Griscelli Syndrome type 2: Experience and outcomes

2019 ◽  
Vol 62 (2) ◽  
pp. 279
Author(s):  
DipendraKumar Mitra ◽  
Devika Gupta ◽  
Deepshi Thakral ◽  
Sameer Bakhshi ◽  
SushilKumar Kabra
2008 ◽  
Vol 0 (0) ◽  
pp. 080428135811547-???
Author(s):  
Alessandro Granito ◽  
Marta Stanzani ◽  
Luigi Muratori ◽  
Dimitrios P. Bogdanos ◽  
Paolo Muratori ◽  
...  

2016 ◽  
Vol 117 (2) ◽  
pp. S114
Author(s):  
Shunji Tomatsu ◽  
Hiromasa Yabe ◽  
Akemi Tanaka ◽  
Yasutsugu Chinen ◽  
Shunichi Kato ◽  
...  

Author(s):  
Theresa Penger ◽  
Andrea Albrecht ◽  
Michaela Marx ◽  
Daniel Stachel ◽  
Markus Metzler ◽  
...  

Summary We report on a boy of Albanian descent with the history of juvenile myelomonocytic leukemia (JMML). JMML was diagnosed at the age of 17 months and treated by hematopoietic stem cell transplantation (HSCT). At the age of 14.3 years, about 12 years after HSCT, he was hospitalized with an adrenal crisis. Hormone findings were consistent with primary adrenal insufficiency. Autoimmune adrenalitis was confirmed by positive autoantibodies against 21-hydroxylase and adrenal tissue. Since autoimmune Hashimoto thyroiditis was already known from the age of 9 years, we assume that both diseases are part of the spectrum of autoimmune polyglandular syndrome (APS) type 2. APS type 2 is a rare endocrine disease characterized by Addison’s disease along with autoimmune thyroid disease and/or type 1 diabetes. Learning points: Endocrine sequelae after hematopoietic stem cell transplantation (HSCT) are common and can develop over a long period. Primary adrenal insufficiency after HSCT is absolutely rare. The combination of adrenal autoimmune disease and Hashimoto thyroiditis is consistent with autoimmune polyglandular syndrome type 2.


Sign in / Sign up

Export Citation Format

Share Document